What are the lasting impacts of RSV, and how can you prevent your infant from getting the infection? Dr. Stephania Cormier is ...
The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...
The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.
As cold and flu season continues in Vermont, UVMMC is urging families to get their newborns and infants preventatively ...
Vermont has the second lowest state fatality rate in the US (145.3 per 100K; Hawaii 112.6/100K). Mississippi (461.9/100K) and ...
The respiratory tract’s microbial microflora plays a significant role in determining the severity of RSV infections and the ...
Doctors at the UVM Medical Center are urging parents and guardians to get Respiratory syncytial virus (RSV) immunizations for ...
Flu, RSV and other respiratory illnesses are sending people to urgent care and emergency rooms. In some cases, these patients ...
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...
Research published in late 2024 in the journal JAMA Pediatrics found nirsevimab was more than 90 percent effective at preventing hospitalization for RSV, and 89 percent effective at preventing all ...
A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...